Brief: Invivyd Announces Continued Neutralizing Activity of PEMGARDA Against Dominant SARS-CoV-2 Variants KP.3.1.1 and LB.1, and Other Variants of Interest
03/09/2024 12:07
Sept 3 (Reuters) - Invivyd Inc IVVD.O :
* INVIVYD ANNOUNCES CONTINUED NEUTRALIZING ACTIVITY OF
PEMGARDA™
(PEMIVIBART) AGAINST DOMINANT SARS-COV-2 VARIANTS KP.3.1.1 AND
LB.1, AND OTHER VARIANTS OF INTEREST
* INVIVYD INC - VYD2311 SHOWS ATTRACTIVE POTENCY AGAINST
CONTEMPORARY VIRUSES
Source text for Eikon: ID:nGNX6rzPyZ
Further company coverage: IVVD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invivyd
See all newsBrief: Invivyd Announces Positive Topline Results From Liberty Phase 3 Study Demonstrating Vyd2311 Safety And Tolerability Superior To Mrna-Based Covid-19 Vaccine Announces Regulatory Submission Plans For Vyd2311
Invivyd, Inc. reports results for the quarter ended June 30 - Earnings Summary
Invivyd Q2 loss per share comes wider than expected on higher costs
Brief: Invivyd Q2 EPS USD -0.14
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview